This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Background & Aims Screening of individuals who have a high risk of pancreatic ductal
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …

For early detection of pancreatic cancer, interests are now focused on the detection of high-
risk individuals to undergo screening examinations. Intraductal papillary mucinous …

Purpose Intraductal papillary mucinous neoplasms (IPMN s) are radiographically visible
precursor lesions of pancreatic cancer. Despite standard criteria for assessing risk, only 18 …

Objective: Previous nomogram models for patients undergoing resection of intraductal
papillary mucinous neoplasms (IPMNs) have been relatively small single-institutional series …

Background The most widely accepted biochemical test for preoperative differentiation of
mucinous from benign, nonmucinous pancreatic cysts is cyst fluid carcinoembryonic antigen …

Background and study aims Biliary strictures are frequently a challenging clinical scenario
and the anatomopathological diagnosis is essential in the therapeutic management …

Cystic pancreatic lesions are common, present in 2.5% of the population 1 and incidentally
detected on 2.2% of computed tomography (CT) examinations of the abdomen and pelvis …

Background A subset of intraductal papillary mucinous neoplasms (IPMNs) will progress to
invasive adenocarcinoma, however identifying invasive from non-invasive disease …

Purpose of review Management of intraductal papillary mucinous neoplasm (IPMN) is
currently based on consensus, in the absence of evidence-based guidelines. In recent …